Used filter(s): 439 items found

  • Remove all filters
  • Search all: Baseball

SLADA Annual Report 2018 (Sri Lanka)

14 Oct 2019

2018 Annual Report / Sri Lanka Anti-Doping Agency (SLADA). - Colombo : SLADA, 2019

ASADA Annual Report 2018-2019 (Australia)

7 Oct 2019

Australian Sports Anti-Doping Authority 2018-19 annual report / Australian Sports Anti-Doping Authority (ASADA). - Canberra : ASADA, 2019

Contents:

  • Ceo Message
  • Overview
  • Annual Performance Statement
  • 2018-2019 Strategic Priorities
  • Management and Accountability
  • Financial Statements
  • Anti-Doping Rule Violation Panel
  • Australian Sports Drug Medical Advisory Committee
  • Appendixes, Abbreviations, Glossary
  • Indixes

AAA 2017 No. 01 17 0004 0880 USADA vs Alberto Salazar

30 Sep 2019

Related cases:

  • AAA 2017 No. 01 17 0003 6197 USADA vs Jeffrey Brown
    September 30, 2019
  • CAS 2019_A_6530 Jeffrey Brown vs USADA | Alberto Salazar vs USADA
    September 15, 2021


Mr. Alberto Salazar is an American track coach and former world-class long-distance runner and the head coach of the Nike Oregon Project (NOP) in Portland, Oregon.

In June 2017 the United States Anti-Doping Agency (USADA) has reported multiple anti-doping rule violations against Mr. Salazar:

1.) Possession of prohibited substances and/or methods including testosterone and prohibited intravenous (IV) infusions and related equipment (such as needles, IV bags and/or syringes, storage containers and other infusion equipment and devices).
2.) Trafficking and/or attempted trafficking of testosterone and prohibited IV infusions.
3.) Administration and/or attempted administration of testosterone and prohibited IV infusions.
4.) Assisting, encouraging, aiding, abetting, covering up, and other complicity involving one or more anti-doping rule violations and/or attempted anti-doping rule violations (“Complicity”).
5.) Tampering and/or attempted tampering.

Also charged is Dr. Jeffrey Brown, a physician and a consultant for the Nike Oregon Project. Here USADA reported multiple anti-doping rule violations against Dr Brown for trafficking, administration, complicity and tampering.

After notification Mr. Salazar filed a statement with evidence in his defence and he was heard for the Tribunal of the American Arbitration Association (AAA).

In this case against Mr. Salazar the Panel has reviewed and examined approximately 1,562 exhibits, heard seven full days of testimony, which are documented in 2,543 pages of hearing transcript, reviewed and carefully considered the parties’ prehearing and post-hearing briefs, which consist of 1,154 pages, reviewed and ruled on various motions and issues that arose between the parties, which are articulated in the 14 Procedural Orders issued by the Panel, and the Panel was required to spend thousands of hours on this matter.

USADA contended with evidence and witness statements that Mr. Salazar was involved in the infusions/injections of L-carnite administered to the Athlete Steve Magness and NOP athletes; possession and use of testosterone gel and tampering together with his attorneys during the investigation and arbitration. During the proceedings USADA did not pursue the Administration or Attempted Administration of Testosterone for personal use.

The Panel finds that USADA has met its burden of proof to show that there was:
1.) A Prohibited Method, an infusion over the applicable limit;
2.) Mr. Magness was an Athlete; and
3.) Mr. Salazar, specifically and aggressively, facilitated and otherwise participated in Mr. Magness’ Use of the Prohibited Method.
Accordingly the Panel finds that Mr. Salazar has committed a anti-doping rule violation of the Rules.

A majority of the Panel finds that USADA has not met its burden of proof with respect to the Attempted administration charge in the matter of the NOP Athletes. Neither with respect to Mr. Salazar committing a Complicity anti-doping rule violation regarding to the Athlete Steve Magness infusion nor to the NOP Athletes.

A majority of the Panel finds that Mr. Salazar did deliberately engage in intentional conduct to alter results or prevent normal procedures from occurring. He was clearly operating under the impression that the NOP Athletes could be asked about infusions and a majority finds he tried to prevent the normal procedure from occurring by instructing the NOP Athletes that no declaration of use of LCarnitine was required and that they should deny they had the L-carnitine infusion when asked about infusions when getting drug tested in or out of competition.

The Panel is concerned that Mr. Salazar conducted a Testosterone Experiment on two non-Athletes, i.e. his own sons, at a reputable and well known training facility, by a very experienced and well known Athlete Support Person, with no actual justification and involving the administration of a controlled substance in potential violation of federal laws. While the Panel accepts Mr. Salazar’s contention that the experiment was designed to protect athletes of the NOP, it could have also been conducted as part of a nefarious attempt to “beat” the testing system and thus is susceptible to creating an appearance of cheating that one could argue would bring the experiment much closer to being “in connection with” an Athlete, Competition or training.

Also regarding the Testosterone Experiment the Panel concludes that Mr. Salazar as Athlete Support Person is strictly prohibited from trafficking in Testostereone by giving it to third parties and committed the anti-doping rule violation for Trafficking. Further the Panel finds that there is insufficient evidence that there was Complicity regarding the Testosterone Experiment and the Panel declines to find a violation here for Tampering based on Mr. Salazar’s conduct in the investigation and arbitration.

Therefore on the basis of the foregoing facts and legal aspects the Panel decides on 30 September 2019:

1.) Respondent has committed the following anti-doping rule violations: Administration, Tampering and Trafficking.
2.) The following sanction shall be imposed on Respondent: a period of Ineligibility (as defined in the World Anti-Doping Code) of four years from the date of this Award, with all attendant consequences.
3.) The parties shall bear their own attorneys’ fees and costs associated with this arbitration.
4.) The administrative fees and expenses of the American Arbitration Association, and the compensation and expenses of the Panel, shall be borne entirely by USADA and the United States Olympic Committee.
5.) This award is in full settlement of all claims and counterclaims submitted to this Arbitration. All claims not expressly granted herein are hereby denied.
6.) This award may be executed in any number of counterparts, each of which shall be deemed an original, and all of which shall constitute together one and the same instrument.

iNADO Update #2019-8

28 Aug 2019

iNADO Update (2019) 8 (28 August)
Institute of National Anti-Doping Organisations (iNADO)


Contents:

- iNADO Board Chair Michael Ask on the future of iNADO and WADA
- Conference Call with WADA
- iNADO CEO Forum Katowice (Nov. 4)
- World Conference on Doping: Registration closes August 30
- Vacancies at the French Anti-Doping Agency
- AMADA offers Athletes a Pro Bono Legal Aid Mechanism
- Athletes Belief in Supplements is undeserved. Recent cases in Australia and Canada
- The Prevalence of Maltreatment in Sport among Top Canadian Athletes
- Brendan Schwab (World Players Association) explains Athletes Protests
- First Report on Testing for Tramadol in Cycling
- IO Reports: Major Event Organisers should store Samples for longer
- Evaluating Anti-Doping Programmes of National Federations
- International Conference on Fitness Doping and Public Health (24-25 Oct., Copenhagen)
- Berlinger: BEREG-Kit celebrates 25 years and New Head of Marketing and Sales
- New at the Anti-Doping Knowledge Center

USADA Annual Report 2018 (United States)

16 Jul 2019

2018 Annual Report U.S. Anti-Doping Agency / United States Anti-Doping Agency (USADA). - Colorado Springs : USADA, 2019

CHINADA Annual Report 2018 (China)

27 Jun 2019

CHINADA 2018 Annual Report / China Anti-Doping Agency (CHINADA). - Beijing : CHINADA, 2019

HZTA Annual Report 2018 (Croatia)

31 May 2019

Croatian Institute for Toxicology and Anti-Doping annual report 2018 / Croatian Institute for Toxicology and Anti-Doping (CITA). - Zagreb : Hrvatski zavod za toksikologiju i antidoping (Antidoping HZTA), 2019

Contents:

  1. Implementation And Improvement Of Legal Framework
  2. Doping Controls, Investigations And Results Management
  3. Doping Prevention
  4. International Cooperation
  5. Therapeutic Use Exemptions
  6. Medicine And Science
  7. Premises And Equipment

Dopingautoriteit Annual Report 2018 (Netherlands)

29 May 2019

Dopingautoriteit Annual Report 2018 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2019

Contents:

Chapter 1 – Prevention
Chapter 2 – Therapeutic Use Exemptions
Chapter 3 – Doping control
Chapter 4 – Intelligence & Investigations
Chapter 5 – Disciplinary Proceedings
Chapter 6 – International Affairs
Chapter 7 – Legal Affairs
Chapter 8 – Scientific research
Chapter 9 – Knowledge management
Chapter 10 – People & organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of the Board of Management, Advisory Board and Committees
Annex 3 - Office staff
Annex 4 - Overview of doping control officials
Annex 5 - Overview of publications and presentations
Annex 6 - Secondary positions
Annex 7 - Abbreviations

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin